Pnc Financial Services Group, Inc. Moon Lake Immunotherapeutics Transaction History
Pnc Financial Services Group, Inc.
- $190 Billion
- Q1 2025
A detailed history of Pnc Financial Services Group, Inc. transactions in Moon Lake Immunotherapeutics stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 9,200 shares of MLTX stock, worth $446,660. This represents 0.0% of its overall portfolio holdings.
Number of Shares
9,200
Previous 8,500
8.24%
Holding current value
$446,660
Previous $451,000
20.4%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding MLTX
# of Institutions
161Shares Held
55.3MCall Options Held
481KPut Options Held
229K-
Bvf Inc San Francisco, CA19.8MShares$959 Million33.91% of portfolio
-
Cormorant Asset Management, LP Boston, MA8.49MShares$412 Million35.2% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.97MShares$144 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.77MShares$134 Million1.75% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il1.48MShares$71.8 Million0.01% of portfolio
About MoonLake Immunotherapeutics
- Ticker MLTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,925,600
- Market Cap $1.79B
- Description
- MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It is developing Sonelokimab, a novel investigational Nanobody therapy for the treatment of inflammation. The company is involved in conducting Phase II trials for hidradenitis suppurativa, psoriatic arthritis, ankylosing spondylitis, or rad...